The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
FoxM1 as a potential therapeutic target for triple-negative breast cancer.
Cha Kyong Yom
No relevant relationships to disclose
Kyung-Min Lee
No relevant relationships to disclose
Wonshik Han
No relevant relationships to disclose
Sung-Won Kim
No relevant relationships to disclose
Hyeong-Gon Moon
No relevant relationships to disclose
Dong-Young Noh
No relevant relationships to disclose